Literature DB >> 24453174

Mycobacterium tuberculosis pellicles express unique proteins recognized by the host humoral response.

Patrick W Kerns1, David F Ackhart, Randall J Basaraba, Jeff G Leid, Mark E Shirtliff.   

Abstract

Mycobacterium tuberculosis (MTB) causes both acute and chronic infections in humans characterized by tolerance to antibiotics and reactivation to cause secondary tuberculosis. These characteristics have led to renewed interest in the in vitro pellicle, or biofilm mode of growth, where bacteria grow to produce a thick aggregate at the air-liquid interface and exhibit increased phenotypic resistance to antibiotics. We infected guinea pigs with the virulent H37Rv strain of MTB for 60 days at which point we collected blood. To identify antigenic proteins, membrane protein extracts of MTB H37Ra pellicles and shaken cultures grown for 3, 5, or 7 weeks were probed with the infected animals' sera after the proteins were separated by two-dimensional gel electrophoresis (2DGE). Antigenic proteins were then identified using MALDI-TOF/TOF mass spectrometry peptide mass fingerprinting. Antigenic pellicle proteins were compared across the three timepoints to identify those that were produced consistently during pellicle growth. They were also compared to those membrane proteins identified from harvested shaken cultures to determine pellicle-specific vs. universally expressed proteins. Using this technique, we identified 44 distinct antigenic proteins, nine of which were pellicle-specific. The sequence of antigenic pellicle-specific proteins was checked for sequence conservation across 15 sequenced MTB clinical isolates, three other members of the MTB complex, as well as M. avium and M. smegmatis. The antigenic pellicle-specific protein Rv0097 was found to have very high sequence conservation within the MTB complex but not with related mycobacteria, while FabG4 was highly conserved in all mycobacteria analyzed. These conserved pellicle-specific proteins represent targets for the development of future diagnostic tests and vaccines.
© 2014 Federation of European Microbiological Societies. Published by John Wiley & Sons Ltd. All rights reserved.

Entities:  

Keywords:  biofilm; humoral; pellicle; proteomics; tuberculosis

Mesh:

Substances:

Year:  2014        PMID: 24453174      PMCID: PMC4363115          DOI: 10.1111/2049-632X.12142

Source DB:  PubMed          Journal:  Pathog Dis        ISSN: 2049-632X            Impact factor:   3.166


  75 in total

1.  The early bactericidal activities of rifampin and rifapentine in pulmonary tuberculosis.

Authors:  Frik A Sirgel; P Bernard Fourie; Peter R Donald; Nesri Padayatchi; Roxana Rustomjee; Jonathan Levin; Giorgio Roscigno; Jennifer Norman; Helen McIlleron; Denis A Mitchison
Journal:  Am J Respir Crit Care Med       Date:  2005-04-01       Impact factor: 21.405

2.  Protein structure prediction on the Web: a case study using the Phyre server.

Authors:  Lawrence A Kelley; Michael J E Sternberg
Journal:  Nat Protoc       Date:  2009       Impact factor: 13.491

3.  Effects of clofazimine on potassium uptake by a Trk-deletion mutant of Mycobacterium tuberculosis.

Authors:  M C Cholo; H I Boshoff; H C Steel; R Cockeran; N M Matlola; K J Downing; V Mizrahi; R Anderson
Journal:  J Antimicrob Chemother       Date:  2005-11-12       Impact factor: 5.790

4.  Identification of Staphylococcus aureus proteins recognized by the antibody-mediated immune response to a biofilm infection.

Authors:  Rebecca A Brady; Jeff G Leid; Anne K Camper; J William Costerton; Mark E Shirtliff
Journal:  Infect Immun       Date:  2006-06       Impact factor: 3.441

5.  A mycobacterial lipoarabinomannan specific monoclonal antibody and its F(ab') fragment prolong survival of mice infected with Mycobacterium tuberculosis.

Authors:  B Hamasur; M Haile; A Pawlowski; U Schroder; G Kallenius; S B Svenson
Journal:  Clin Exp Immunol       Date:  2004-10       Impact factor: 4.330

Review 6.  Comparative genomics of mycobacterial proteases.

Authors:  Michelle Lopes Ribeiro-Guimarães; Maria Cristina Vidal Pessolani
Journal:  Microb Pathog       Date:  2007-06-02       Impact factor: 3.738

7.  Induction of a protective response with an IgA monoclonal antibody against Mycobacterium tuberculosis 16kDa protein in a model of progressive pulmonary infection.

Authors:  Yamilé López; Daniel Yero; Gustavo Falero-Diaz; Nesty Olivares; María E Sarmiento; Sergio Sifontes; Rosa L Solis; Jorge A Barrios; Diana Aguilar; Rogelio Hernández-Pando; Armando Acosta
Journal:  Int J Med Microbiol       Date:  2009-01-20       Impact factor: 3.473

8.  Keto-mycolic acid-dependent pellicle formation confers tolerance to drug-sensitive Mycobacterium tuberculosis.

Authors:  Dhinakaran Sambandan; Dee N Dao; Brian C Weinrick; Catherine Vilchèze; Sudagar S Gurcha; Anil Ojha; Laurent Kremer; Gurdyal S Besra; Graham F Hatfull; William R Jacobs
Journal:  mBio       Date:  2013-05-07       Impact factor: 7.867

9.  Identification of putative biomarkers for the serodiagnosis of drug-resistant Mycobacterium tuberculosis.

Authors:  Lu Zhang; Qingzhong Wang; Wenjie Wang; Yanyan Liu; Jie Wang; Jun Yue; Ying Xu; Wenxi Xu; Zhenling Cui; Xuelian Zhang; Honghai Wang
Journal:  Proteome Sci       Date:  2012-02-25       Impact factor: 2.480

10.  The genetic requirements for fast and slow growth in mycobacteria.

Authors:  Dany J V Beste; Mateus Espasa; Bhushan Bonde; Andrzej M Kierzek; Graham R Stewart; Johnjoe McFadden
Journal:  PLoS One       Date:  2009-04-28       Impact factor: 3.240

View more
  12 in total

1.  Rapid adaptation of a complex trait during experimental evolution of Mycobacterium tuberculosis.

Authors:  Tracy M Smith; Madison A Youngblom; John F Kernien; Mohamed A Mohamed; Sydney S Fry; Lindsey L Bohr; Tatum D Mortimer; Mary B O'Neill; Caitlin S Pepperell
Journal:  Elife       Date:  2022-06-21       Impact factor: 8.713

2.  Protein Integrated Network Analysis to Reveal Potential Drug Targets Against Extended Drug-Resistant Mycobacterium tuberculosis XDR1219.

Authors:  Noor Ul Ain Zahra; Faiza Jamil; Reaz Uddin
Journal:  Mol Biotechnol       Date:  2021-08-11       Impact factor: 2.695

3.  Comparative Proteomic Analysis of Aminoglycosides Resistant and Susceptible Mycobacterium tuberculosis Clinical Isolates for Exploring Potential Drug Targets.

Authors:  Divakar Sharma; Bhavnesh Kumar; Manju Lata; Beenu Joshi; Krishnamurthy Venkatesan; Sangeeta Shukla; Deepa Bisht
Journal:  PLoS One       Date:  2015-10-05       Impact factor: 3.240

4.  Effects of nutritional and ambient oxygen condition on biofilm formation in Mycobacterium avium subsp. hominissuis via altered glycolipid expression.

Authors:  Takahiro Totani; Yukiko Nishiuchi; Yoshitaka Tateishi; Yutaka Yoshida; Hiromi Kitanaka; Mamiko Niki; Yukihiro Kaneko; Sohkichi Matsumoto
Journal:  Sci Rep       Date:  2017-02-03       Impact factor: 4.379

Review 5.  Proteomics progresses in microbial physiology and clinical antimicrobial therapy.

Authors:  B Chen; D Zhang; X Wang; W Ma; S Deng; P Zhang; H Zhu; N Xu; S Liang
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-11-04       Impact factor: 3.267

6.  S-Enantiomer of the Antitubercular Compound S006-830 Complements Activity of Frontline TB Drugs and Targets Biogenesis of Mycobacterium tuberculosis Cell Envelope.

Authors:  Padam Singh; Shashi Kant Kumar; Vineet Kumar Maurya; Basant Kumar Mehta; Hafsa Ahmad; Anil Kumar Dwivedi; Vinita Chaturvedi; Tejender S Thakur; Sudhir Sinha
Journal:  ACS Omega       Date:  2017-11-30

7.  Advance in Research on Mycobacterium tuberculosis FabG4 and Its Inhibitor.

Authors:  Debajyoti Dutta
Journal:  Front Microbiol       Date:  2018-06-06       Impact factor: 5.640

8.  Naturally produced opsonizing antibodies restrict the survival of Mycobacterium tuberculosis in human macrophages by augmenting phagosome maturation.

Authors:  Shashi Kant Kumar; Padam Singh; Sudhir Sinha
Journal:  Open Biol       Date:  2015-12       Impact factor: 6.411

9.  Vaccines Directed Against Microorganisms or Their Products Present During Biofilm Lifestyle: Can We Make a Translation as a Broad Biological Model to Tuberculosis?

Authors:  Mario A Flores-Valdez
Journal:  Front Microbiol       Date:  2016-01-21       Impact factor: 5.640

10.  Identification of Mycobacterium tuberculosis Peptides in Serum Extracellular Vesicles from Persons with Latent Tuberculosis Infection.

Authors:  Carolina Mehaffy; Nicole A Kruh-Garcia; Barbara Graham; Leah G Jarlsberg; Charis E Willyerd; Andrey Borisov; Timothy R Sterling; Payam Nahid; Karen M Dobos
Journal:  J Clin Microbiol       Date:  2020-05-26       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.